Aging and Regenerative Medicine
Advances made in research on the biology of aging and on the repair, replacement, and regeneration of tissues and organs (regenerative medicine) have drawn attention to old and new ethical issues. The principal concern among those who anticipate intervention in the aging process is whether or not attaining the power to do so is a desirable goal. The issues for those who are concerned about using human cells or tissues for research or therapeutic purposes are as follows: (1) whether the donor is, or is not, capable of giving informed consent; (2) if not, whether it is ethical for others to make that decision; and (3) whether the taking of one or a few potential lives for the benefit of many is ethically sound. When the source of the cells or tissues is a fetus or embryo, debate centers on the ethics of using tissue from induced or spontaneous abortion and when human life begins.
Where some see only benefit in the ability to slow, stop, or even reverse the aging process, others see an array of unintended consequences. There have been efforts made to intervene in the aging process throughout recorded history, and also warnings given that doing so could lead to undesirable consequences (Hayflick 2000).
This page contains 201 words.

Aging and Regenerative Medicine article
Read the rest of this article.
This article contains 2,399 words
(approx. 8 pages at 300 words per page).